# Tom Paschall

> Tom Paschall is a venture - series unknown investor at Checkmate Capital backing Medical. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Checkmate Capital](https://shizune.co/investors/profile/checkmate-capital)
- Location: Los Angeles, United States
- Total investments: 1
- Last investment: Dec 2025
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/tom-paschall-cc/

Tom Paschall is a venture - series unknown investor at Checkmate Capital in Los Angeles focused on Medical and Biotechnology. Tom Paschall is the CEO at Checkmate Capital Group. Tom attended USC Gould School of Law.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biotechnology | 1 | 100% |
| Developer Platform | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NeuroSigma | NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma is focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD).NeuroSigma is actively engaged in cutting-edge preclinical research and development, as well as groundbreaking Phase I, II, & III clinical trials. | $1M | Venture - Series Unknown | Dec 15, 2025 |  |

1 of 1 investments shown.

## About Checkmate Capital

VC Fund · Pasadena, United States

The diverse experience of the Checkmate Capital team allows us to invest confidently across a range of industries including bio tech, ag tech, waste and energy.

2 contacts available at Checkmate Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Scott Shaw | Managing Director & Partner | https://shizune.co/investors/profile/scott-shaw |
| Tom Paschall | Chief Executive Officer | https://shizune.co/investors/profile/tom-paschall-4d80 |

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Tom Paschall invest in?

Tom Paschall invests primarily in Medical, Biotechnology and Developer Platform startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Tom Paschall last invest?

The most recent investment recorded for Tom Paschall closed in Dec 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co